About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Leukemia Clinical Trials | 379 Studies Recruiting

Clinical TrialsLeukemia

Leukemia Clinical Trials

Browse 379 clinical trials for leukemia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 379 trials

UnknownDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaRATIONALE: Giving low doses of chemotherapy before a donor stem cell transplant using stem cells that closely match the patient's stem cells, helps stop the growth of cancer cells.NCT00295997·San Francisco, California and 1 other CompletedPhase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)This is an open-label, Phase I study to determine the highest amount of the study drug, ON 01910.Na, that can be safety given to patients with high risk myelodysplastic syndromes…NCT00854646·New York, New York TerminatedPhase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral InfectionsAllogeneic hematopoetic stem cell transplantation (SCT) is frequently complicated by life threatening viral reactivation.NCT02231853·Bethesda, Maryland

Related Searches

amltrials cmltrials alltrials clltrials

Data from ClinicalTrials.govTerms

CompletedNon-Ablative Allo HSCT For Hematologic Malignancies or SAARATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00006379·Cleveland, Ohio

CompletedIL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCTThis is a multi-center, phase I/II clinical trial for patients who have relapsed more than 60 day after allogeneic transplant for a hematologic malignancy.NCT01885897·Minneapolis, Minnesota and 2 others

CompletedPrevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell CountRATIONALE: Antibiotic therapy may prevent the development of infection in patients with hematologic cancer and the persistent fever caused by a low white blood cell count.NCT00003805·Baltimore, Maryland and 27 others

CompletedMyeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesRATIONALE: Giving chemotherapy drugs, such as fludarabine and cyclophosphamide, and total-body irradiation before a donor umbilical cord blood stem cell transplant helps stop the…NCT00309842·Minneapolis, Minnesota and 1 other

CompletedNMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersRATIONALE: Giving low doses of chemotherapy before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells.NCT00053989·Buffalo, New York

CompletedFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerThis clinical trial studies the side effects and best dose of giving fludarabine and total-body irradiation (TBI) together followed by a donor stem cell transplant and…NCT00112593·Seattle, Washington

CompletedMassage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for CancerThis clinical trial studies massage therapy given by caregiver in treating quality of life of young patients undergoing treatment for cancer.NCT01053494·Winston-Salem, North Carolina

CompletedCombination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic SyndromeRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00002502·New York, New York

CompletedA Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.This study will determine the maximum tolerated dose of RO5045337 and the optimal associated 4 weekly dosing schedule of RO5045337, administered as monotherapy in patients with…NCT00623870·Duarte, California and 10 others

CompletedA Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesThe purpose of this study is to determine the maximum tolerated dose (MTD) of TAK-901 in subjects with advanced hematological malignancies, and to further assess the safety and…NCT00807677·Ann Arbor, Michigan

WithdrawnBusulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerRATIONALE: Drugs used in chemotherapy, such as busulfan and fludarabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them…NCT00301912·San Francisco, California

CompletedExperimental Bone Marrow Transplant ProtocolBone marrow transplantation (BMT) is a risky procedure. If doctors could reduce the complications, BMT would be safer to use for a wider range of conditions.NCT00061581·Bethesda, Maryland

CompletedImmunotoxin in Treating Patients With Leukemia or LymphomaRATIONALE: Immunotoxins can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00002765·Bethesda, Maryland and 1 other

UnknownLight-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow TransplantationRATIONALE: Light-emitting diode (LED) therapy may be able to prevent mucositis of the mouth.NCT00036712·Milwaukee, Wisconsin

CompletedTotal Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic DiseasesIn this study, patients will receive a myeloablative preparative regimen consisting of fludarabine and total body irradiation (TBI), followed by a T cell replete, mobilized…NCT01336712·Atlanta, Georgia

CompletedSirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological CancerRATIONALE: Giving chemotherapy and total-body irradiation before a donor peripheral blood stem cell transplant helps stop the growth of cancer cells.NCT00589563·Phoenix, Arizona and 1 other

CompletedOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantRATIONALE: Ondansetron may help lessen or prevent nausea and vomiting in patients undergoing stem cell transplant.NCT00795769·Seattle, Washington

PreviousPage 3 of 19Next